Ensign Peak Advisors’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.4M | Buy |
87,219
+19,786
| +29% | +$1.45M | 0.01% | 585 |
|
|
2025
Q1 | $7.7M | Buy |
67,433
+19,504
| +41% | +$2.23M | 0.01% | 531 |
|
|
2024
Q4 | $2.42M | Buy |
47,929
+11,040
| +30% | +$556K | ﹤0.01% | 862 |
|
|
2024
Q3 | $1.71M | Hold |
36,889
| – | – | ﹤0.01% | 1019 |
|
|
2024
Q2 | $1.2M | Hold |
36,889
| – | – | ﹤0.01% | 1168 |
|
|
2024
Q1 | $929K | Sell |
36,889
-1,861
| -5% | -$46.9K | ﹤0.01% | 1377 |
|
|
2023
Q4 | $1.26M | Hold |
38,750
| – | – | ﹤0.01% | 1204 |
|
|
2023
Q3 | $1.06M | Hold |
38,750
| – | – | ﹤0.01% | 1160 |
|
|
2023
Q2 | $862K | Hold |
38,750
| – | – | ﹤0.01% | 1380 |
|
|
2023
Q1 | $839K | Buy |
38,750
+1,250
| +3% | +$27.1K | ﹤0.01% | 1390 |
|
|
2022
Q4 | $762K | Buy |
37,500
+9,500
| +34% | +$193K | ﹤0.01% | 1389 |
|
|
2022
Q3 | $718K | Sell |
28,000
-10,750
| -28% | -$276K | ﹤0.01% | 1261 |
|
|
2022
Q2 | $921K | Hold |
38,750
| – | – | ﹤0.01% | 1150 |
|
|
2022
Q1 | $873K | Hold |
38,750
| – | – | ﹤0.01% | 1282 |
|
|
2021
Q4 | $767K | Sell |
38,750
-48,650
| -56% | -$963K | ﹤0.01% | 1411 |
|
|
2021
Q3 | $1.72M | Hold |
87,400
| – | – | ﹤0.01% | 1206 |
|
|
2021
Q2 | $1.92M | Buy |
87,400
+1,800
| +2% | +$39.6K | ﹤0.01% | 1153 |
|
|
2021
Q1 | $2.04M | Buy |
85,600
+33,300
| +64% | +$792K | ﹤0.01% | 1105 |
|
|
2020
Q4 | $1.37M | Buy |
52,300
+17,800
| +52% | +$466K | ﹤0.01% | 1261 |
|
|
2020
Q3 | $600K | Hold |
34,500
| – | – | ﹤0.01% | 1482 |
|
|
2020
Q2 | $580K | Hold |
34,500
| – | – | ﹤0.01% | 1431 |
|
|
2020
Q1 | $410K | Buy |
+34,500
| New | +$410K | ﹤0.01% | 1433 |
|